Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Bronchioloalveolar carcinoma

Lau SK, Desrochers MJ, Luthringer DJ. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas an immunohistochemical evaluation of 67 cases. Mod Pathol. 2002 15 538-542. [Pg.247]

These results indicated that mucinous bronchioloalveolar carcinomas were frequently TTF-l-negative and could express CK20. [Pg.399]

Saad RS, Liu Y, Han H, et al. Prognostic significance of HER2/ neu, p53 and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Mod Pathol. 2004 17 1234-1242. [Pg.452]

Simsir A, Wei XJ, Yee H, et al. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma an immunohistochemical study in fine needle aspiration biopsy specimens. Am J Clin Pathol. 2004 121 350-357. [Pg.452]

Singh G, Katyal SL, Torikata C. Carcinoma of type II pneu-mocytes Immunodiagnosis of a subtype of bronchioloalveolar carcinoma. Am J Pathol. 1981 102 195-208. [Pg.456]

Shah RN, Badve S, Papreddy K, et al. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Hum Pathol. 2002 33 915-920. [Pg.536]

Bellocq A, Antoine M, Flahault A, Philippe C, Crestani B, Bernaudin JF, Mayaud C, Milleron B, Baud L, Cadranel J Neutrophil alveolitis in bronchioloalveolar carcinoma Induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol 1998 152 83-92. [Pg.198]

Tan RT, Kuzo RS. High-resolution CT findings of mucinous bronchioloalveolar carcinoma a case of pseudopuhnonary alveolar proteinosis. AJR Am J Roentgenol 1997 168(1) 99-100. [Pg.39]

Recurrence of the primary disease in the transplanted lung has been reported for several diseases, for example sarcoidosis, pulmonary Langerhans cell histiocytosis, giant cell interstitial pneumonia, LAM and bronchioloalveolar carcinoma. [Pg.150]

There is controversy regarding whether bronchioloalveolar carcinoma should be accepted as an indication for LuTX. A recurrence of the disease within the donor lungs was noted in four of seven lung-transplanted patients by Carver et al. (1999). At the University of Birmingham Zorn et al. (2003) transplanted nine patients with bronchioloalveolar carcinoma and just two of them were free from recurrence. [Pg.150]

Carver RI Jr., Zorn GL, Wu X, McGiffin DC, Young KR Jr., Pinkard NB (1999) Recurrence of bronchioloalveolar carcinoma in transplanted lungs. N Engl JMed340(14) 1071-1074... [Pg.151]

Zorn GL, McGiffin DC, Young KR Jr., Alexander CB, Weill D, Kirklin JK (2003) Pulmonary transplantation for advanced bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 125 45-48... [Pg.152]

Marchetti A, Pellegrini S, Bertacca G, et al. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations. J Pathol 1998 184 240-246. [Pg.266]

See other pages where Bronchioloalveolar carcinoma is mentioned: [Pg.148]    [Pg.240]    [Pg.381]    [Pg.399]    [Pg.399]    [Pg.402]    [Pg.402]    [Pg.458]    [Pg.124]    [Pg.514]    [Pg.276]    [Pg.254]    [Pg.170]    [Pg.172]    [Pg.173]   
See also in sourсe #XX -- [ Pg.150 , Pg.170 ]



SEARCH



© 2024 chempedia.info